{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:52Z","timestamp":1786988152077,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejps.2024.106857","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T04:25:47Z","timestamp":1721276747000},"page":"106857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Ameliorating effects of the HIF-2\u03b1 inhibitor PT2385 on high-altitude polycythemia"],"prefix":"10.1016","volume":"201","author":[{"given":"Kang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesang","family":"Luobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawa","family":"Ciren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-1270","authenticated-orcid":false,"given":"Qijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106857_bib0001","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.arthro.2016.07.031","article-title":"High altitude is an independent risk factor for postoperative symptomatic venous thromboembolism after knee arthroscopy: a matched case-control study of medicare patients","volume":"33","author":"Cancienne","year":"2017","journal-title":"Arthroscopy"},{"key":"10.1016\/j.ejps.2024.106857_bib0002","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2024.106857_bib0003","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1200\/JCO.2017.74.2627","article-title":"Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2\u03b1 antagonist in patients with previously treated advanced clear cell renal cell carcinoma","volume":"36","author":"Courtney","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2024.106857_bib0004","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/1078-0432.CCR-19-1459","article-title":"HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma","volume":"26","author":"Courtney","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2024.106857_bib0005","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000163580.98098.A3","article-title":"Endothelium intrinsic requirement for Hif-2\u03b1 during vascular development","volume":"111","author":"Duan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2024.106857_bib0006","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1082-3","article-title":"YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma","volume":"18","author":"Hou","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejps.2024.106857_bib0007","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1172\/JCI39506","article-title":"Hypoxia-inducible factor 2\u03b1 regulates macrophage function in mouse models of acute and tumor inflammation","volume":"120","author":"Imtiyaz","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejps.2024.106857_bib0008","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1055\/s-0038-1657770","article-title":"Genome-wide expression analysis suggests hypoxia-triggered hyper-coagulation leading to venous thrombosis at high altitude","volume":"118","author":"Jha","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejps.2024.106857_bib0009","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.3892\/etm.2017.4996","article-title":"Mechanism of apoptosis involved in gastric mucosal lesions in Tibetans with high-altitude polycythemia","volume":"14","author":"Li","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejps.2024.106857_bib0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/pgmj.2008.068296","article-title":"From mountain to bedside: understanding the clinical relevance of human acclimatisation to high-altitude hypoxia","volume":"84","author":"Martin","year":"2008","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejps.2024.106857_bib0011","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/HYPERTENSIONAHA.118.11140","article-title":"Systemic hypertension at high altitude","volume":"72","author":"Narvaez-Guerra","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ejps.2024.106857_bib0012","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ejps.2024.106857_bib0013","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msw280","article-title":"Down-regulation ofEPAS1 transcription and genetic adaptation of tibetans to high-altitude hypoxia","author":"Peng","year":"2017","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ejps.2024.106857_bib0014","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI30117","article-title":"Hypoxia-inducible factor\u20132 (HIF-2) regulates hepatic erythropoietin in vivo","volume":"117","author":"Rankin","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejps.2024.106857_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.715222","article-title":"Protective effects of Hif2 inhibitor PT-2385 on a neurological disorder induced by deficiency of Irp2","volume":"15","author":"Shen","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejps.2024.106857_bib0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood-2008-12-193581","article-title":"Endothelial deletion of hypoxia-inducible factor\u20132\u03b1 (HIF-2\u03b1) alters vascular function and tumor angiogenesis","volume":"114","author":"Skuli","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2024.106857_bib0017","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI57322","article-title":"Endothelial HIF-2\u03b1 regulates murine pathological angiogenesis and revascularization processes","volume":"122","author":"Skuli","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejps.2024.106857_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.101052","article-title":"Altitude acclimatization, hemoglobin-oxygen affinity, and circulatory oxygen transport in hypoxia","volume":"84","author":"Storz","year":"2022","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ejps.2024.106857_bib0019","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/ham.2015.0015","article-title":"The local HIF-2\u03b1\/EPO pathway in the bone marrow is associated with excessive erythrocytosis and the increase in bone marrow microvessel density in chronic mountain sickness","volume":"16","author":"Su","year":"2015","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.ejps.2024.106857_bib0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00109-017-1519-3","article-title":"Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2\u03b1) polymorphism lowers hemoglobin concentration in Tibetan highlanders","volume":"95","author":"Tashi","year":"2017","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejps.2024.106857_bib0021","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood-2013-05-500207","article-title":"Hypoxia-inducible factor 2\u03b1 regulates key neutrophil functions in humans, mice, and zebrafish","volume":"123","author":"Thompson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2024.106857_bib0022","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2013-05-501924","article-title":"Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype","volume":"123","author":"Tyagi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2024.106857_bib0023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ham.2016.0031","article-title":"Chronic mountain sickness: clinical aspects, etiology, management, and treatment","volume":"17","author":"Villafuerte","year":"2016","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.ejps.2024.106857_bib0024","article-title":"A transgenic mouse model of Pacak\u2013Zhuang syndrome with an epas1 gain-of-function mutation","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejps.2024.106857_bib0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2022.03.027","article-title":"Clinicopathological characteristics of high-altitude polycythemia-related kidney disease in Tibetan inhabitants","volume":"102","author":"Wang","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejps.2024.106857_bib0026","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/ham.2021.0075","article-title":"Platelets and high-altitude exposure: a meta-analysis","volume":"23","author":"Wang","year":"2022","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.ejps.2024.106857_bib0027","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2022.2157381","article-title":"Apoptosis is one cause of thrombocytopenia in patients with high-altitude polycythemia","volume":"34","author":"Wang","year":"2023","journal-title":"Platelets"},{"key":"10.1016\/j.ejps.2024.106857_bib0028","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.4412","article-title":"Activation of intestinal hypoxia-inducible factor 2\u03b1 during obesity contributes to hepatic steatosis","volume":"23","author":"Xie","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2024.106857_bib0029","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1182\/blood-2007-11-122648","article-title":"The microenvironment for erythropoiesis is regulated by HIF-2\u03b1 through VCAM-1 in endothelial cells","volume":"112","author":"Yamashita","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2024.106857_bib0030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41440-022-00955-8","article-title":"Prevalence of hypertension and its relationship with altitude in highland areas: a systematic review and meta-analysis","volume":"45","author":"Zhang","year":"2022","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejps.2024.106857_bib0031","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/bph.15696","article-title":"Established pulmonary hypertension in rats was reversed by a combination of a HIF-2\u03b1 antagonist and a p53 agonist","volume":"179","author":"Zheng","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106857_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09277-9","article-title":"A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis","volume":"10","author":"Zou","year":"2019","journal-title":"Nat. Commun."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T19:33:17Z","timestamp":1724700797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":32,"alternative-id":["S0928098724001696"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106857","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ameliorating effects of the HIF-2\u03b1 inhibitor PT2385 on high-altitude polycythemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106857"}}